Items where authors include "Claxton, K."
![[up]](/style/images/multi_up.png)
Up a levelArticle
Johannesen, K.M., Claxton, K., Sculpher, M.J. et al. (1 more author) (2018) How to design the cost-effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework. Health Economics, 27 (2). e41-e54. ISSN 1057-9230
Colbourn, T.E., Asseburg, C., Bojke, L. et al. (5 more authors) (2007) Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses. BMJ, 335 (7621). 655-658A. ISSN 0959-8146
Claxton, K. (2007) OFT, VBP: QED? Health Economics, 16 (6). pp. 545-558. ISSN 1057-9230
Culyer, A., McCabe, C., Briggs, A. et al. (5 more authors) (2007) Searching for a threshold, not setting one: The role of the National Institute for Health and Clinical Excellence. Journal of Health Services Research & Policy. pp. 56-58. ISSN 1758-1060
Claxton, K. and Culyer, A.J. (2006) Wickedness or folly? The ethics of NICE's decisions. Journal of Medical Ethics, 32 (7). pp. 373-377. ISSN 0306-6800
Claxton, K. orcid.org/0000-0003-2002-4694, Palmer, S. orcid.org/0000-0002-7268-2560, Bojke, L. orcid.org/0000-0001-7921-9109 et al. (2 more authors) (2006) Priority setting for research in health care: An application of value of information analysis to glycoprotein IIb/IIIa antagonists in non-ST elevation acute coronary syndrome. International Journal of Technology Assessment in Health Care. pp. 379-387. ISSN 0266-4623
Claxton, K. orcid.org/0000-0003-2002-4694, Raftery, J., McCabe, C. et al. (1 more author) (2006) Orphan drugs revisited:[comment]. QJM Monthly Journal of the Association of Physicians. discussion 350. pp. 341-5. ISSN 1460-2393
Nelson, E.A., O'Meara, S., Craig, D. et al. (10 more authors) (2006) A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers. Health Technology Assessment, 10 (12). pp. 1-235. ISSN 1366-5278
Ades, A.E., Claxton, K. and Sculpher, M. (2006) Evidence Synthesis, Parameter Correlation, and Probabilistic Sensitivity Analysis. Health Economics, 15 (4). pp. 373-381. ISSN 1057-9230
Iglesias, C.P. and Claxton, K. (2006) Comprehensive decision analytic model and Bayesian value of information analysis: pentoxifylline in the treatment of chronic venous leg ulcers. Pharmacoeconomics, 24 (5). pp. 465-478. ISSN 1170-7690
Woolacott, N., Bravo Vergel, Y., Hawkins, N. et al. (10 more authors) (2006) Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review. Clinical and Experimental Rheumatology, 24 (5). pp. 587-593. ISSN 1593-098X
Claxton, K. orcid.org/0000-0003-2002-4694, McCabe, C. and Tsuchiya, A. (2005) Orphan drugs and the NHS: Should we value rarity. BMJ. pp. 1016-1019. ISSN 1756-1833
Claxton, K., Sculpher, M., McCabe, C. et al. (5 more authors) (2005) Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Economics, 14 (4). pp. 339-347. ISSN 1057-9230
Ginnelly, L., Claxton, K., Sculpher, M.J. et al. (1 more author) (2005) Using value of information analysis to inform publicly funded research priorities. Applied Health Economics and Health Policy, 4 (1). pp. 37-46. ISSN 1175-5652
Philips, Z., Ginnelly, L., Sculpher, M. et al. (5 more authors) (2004) Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technology Assessment, 8 (36). pp. 1-169. ISSN 1366-5278
Cooper, N.J., Claxton, K. orcid.org/0000-0003-2002-4694, Chilcott, J. et al. (4 more authors) (2003) Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. BMJ. pp. 522-525. ISSN 1756-1833
Claxton, K. and Thompson, K. M. (2001) A Dynamic Programming Approach to Efficient Clinical Trial Design. Journal of Health Economics, 20 (5). pp. 797-822. ISSN 0167-6296
Luce, B.R., Shih, Y.T. and Claxton, K. orcid.org/0000-0003-2002-4694 (2001) Bayesian approaches to technology assessment and decision making. International Journal of Technology Assessment in Health Care. pp. 1-5. ISSN 0266-4623
Claxton, K. orcid.org/0000-0003-2002-4694, Neumann, P.J., Araki, S. et al. (1 more author) (2001) Bayesian value-of-infomation analysis: an application to a policy model of Alzheimer's disease. International Journal of Technology Assessment in Health Care. pp. 38-55. ISSN 0266-4623
Monograph
Claxton, K. orcid.org/0000-0003-2002-4694, Palmer, S. orcid.org/0000-0002-7268-2560, Sculpher, M. orcid.org/0000-0003-3746-9913 et al. (1 more author) (2010) Appropriate perspectives for health care decisions. Discussion Paper. CHE Research Paper . Centre for Health Economics, University of York , York, UK.
McKenna, C. orcid.org/0000-0002-7759-4084, Chalabi, Z., Epstein, D. et al. (1 more author) (2008) Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisions. Working Paper. CHE Research Paper . Centre for Health Economics, University of York , York, UK.
Claxton, K. orcid.org/0000-0003-2002-4694, Sculpher, M. orcid.org/0000-0003-3746-9913 and Culyer, A. (2007) Mark versus Luke? Appropriate methods for the evaluation of public health interventions. Working Paper. CHE Research Paper . Centre for Health Economics, University of York , York, UK.
Bojke, L., Claxton, K., Palmer, S. et al. (1 more author) (2006) Defining and characterising structural uncertainty in decision analytic models. Research Report. CHE Research Paper (9). Centre for Health Economics , York, UK.
Claxton, K. orcid.org/0000-0003-2002-4694, McCabe, C., Tsuchiya, A. et al. (1 more author) (2006) Drugs for exceptionally rare diseases: a commentary on Hughes et al. Discussion Paper. QJM
Fenwick, E., Claxton, K. and Sculpher, M. (2005) The value of implementation and the value of information: combined and uneven development. Research Report. CHE Research Paper (5). Centre for Health Economics , York, UK.
Claxton, K., Eggington, S., Ginnelly, L. et al. (5 more authors) (2005) A pilot study of value of information analysis to support research recommendations for NICE. Research Report. CHE Research Paper (4). Centre for Health Economics , York, UK.
Proceedings Paper
Vervaart, M., Heath, A., Aas, E. et al. (4 more authors) (2022) EE436: General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations. In: Value in Health. ISPOR Europe 2022, 06-09 Nov 2022, Vienna, Austria. Elsevier Inc. , S141-S141.
Vervaart, M., Aas, E., Claxton, K. et al. (3 more authors) (2021) Expected value of sample information for survival data from ongoing trials. In: Medical Decision Making. 2020 North America Annual Meeting for SMDM, 06-27 Oct 2020, Virtual. SAGE Publications , E343-E344.
Preprint
Claxton, K. orcid.org/0000-0003-2002-4694, Sculpher, M. orcid.org/0000-0003-3746-9913 and Carroll, S. (2011) Value-based pricing for pharmaceuticals:its role, specification and prospects in a newly devolved NHS. [Preprint]